AI-powered closed-loop manufacturing platform for autologous CAR‑T and other advanced cell therapies, combining predictive analytics, robotic bioprocessing and digital quality systems. Provides scalable, high-fidelity CDMO-grade production for biopharma and therapy innovators aiming to accelerate discovery-to-patient timelines.